A review of web-based weight loss interventions in adults
- PMID: 20804523
- PMCID: PMC3086798
- DOI: 10.1111/j.1467-789X.2010.00787.x
A review of web-based weight loss interventions in adults
Abstract
Unprecedented obesity rates are changing the burden of disease worldwide and obesity-related health complications are increasing healthcare costs. In response, researchers, clinicians and public health practitioners are seeking new and effective tools such as the Internet to effect weight loss. This review highlights peer-reviewed literature on randomized controlled trials that examine Internet-delivered weight loss and maintenance programmes. The scope of this review is broader than previous reviews, including more males and non-Caucasian participants. The reviewed studies show intervention results ranging from no weight loss to an average loss of 7.6 kg. It is difficult to draw a definitive conclusion on the potential impact of Internet-based weight loss as study methods are highly variable between papers, low adherence was recorded and not all studies include a control group. As the demand for low-cost, efficacious interventions that yield statistically significant and/or clinically relevant results grows, more rigorous, population-specific research is needed to determine if Internet-delivered interventions may slow or reverse with weight gain and obesity and the associated health consequences.
No claim to original US government works. obesity reviews © 2010 International Association for the Study of Obesity.
Conflict of interest statement
Conflicts of interest: None
References
-
- Fact sheets from the Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. W V Med J. 2002 Nov–Dec;98(6):234–243. - PubMed
-
- Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010 Jan 20;303(3):235–241. - PubMed
-
- Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 2002 Mar–Apr;21(2):245–253. - PubMed
-
- Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J for the RIONASG. Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial. JAMA. 2006 February 15;295(7):761–775. 2006. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
